Skip to Main Content
Cancer HealthCast 36m listen

Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy

NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.

Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.

Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).

Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.

Related Content
Woman typing at computer

Stay in the know

Subscribe now to receive our curated newsletters